Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01435746

Transfusion Requirements After Orthotopic Liver Transplantation

A Randomized, Controlled Pilot Trial of Transfusion Requirements After Orthotopic Liver

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University Medical Center Goettingen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this trial is to evaluate different transfusion strategies in patients after liver transplantation. Patients in the experimental arm will be given red blood cell (RBC) transfusion according to a liberal strategy, i. e., transfusions should be given, when hemoglobin concentration falls below 10 g/dl, and hemoglobin concentration should be maintained between 10 and 12 g/dl. Patients in the control arm will be given red blood cell (RBC) transfusion according to a restrictive strategy, i. e., transfusions should be given, when hemoglobin concentration falls below 8 g/dl, and hemoglobin concentration should be maintained between 8 and 10 g/dl.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRed blood cell transfusionThe intervention of this trial is the regime of red blood cell transfusion. The control group will receive red blood cell transfusions according to a conservative regime, whereas the experimental group will receive red blood cell transfusion according to a liberal transfusion regime.

Timeline

Start date
2011-11-01
Primary completion
2012-11-01
Completion
2013-11-01
First posted
2011-09-19
Last updated
2022-08-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01435746. Inclusion in this directory is not an endorsement.